FDA Inspection 1272168 — Paxman US Inc.

Paxman US Inc. — FEI 3014209575

The FDA completed an inspection of Paxman US Inc. on May 15, 2025 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
May 15, 2025
Fiscal Year
2025
Product Type
Devices
Project Area
Compliance: Devices
Location
Houston, TX (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.